ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756471 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756471; 2) Community: the network communities that were significantly associated with the response to NSC 756471; 3) Molecule: the relationships between components within communities and NSC 756471; 4) MDR: the compounds that were significantly associated with the NSC 756471.

NSC Compound Enrichment Correlation
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0112425217758227 0.37427787
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0112425217758227 0.49337597
NSC 756169 GSK317314A 0.0112425217758227 0.57759284
NSC 758682 ARTENIMOL 0.0112425217758227 0.42705936
NSC 760980 Null 0.0112425217758227 0.34164214
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0114553853234976 0.39186864
NSC 7821 [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride 0.0114553853234976 0.0189498
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0114553853234976 0.3798099
NSC 114346 Null 0.0114553853234977 0.60631785
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0114553853234977 0.5478992
Total:154  Current:61    [First] [Prev] [Next] [Last]